Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-033881)

Filing Details

Accession Number:: 0001127602-13-033881
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-12-06 13:32:06
Reporting Period:: 2012-12-05

Filing Date:: 2013-12-06
Accepted Time:: 2013-12-06 13:32:06
Original Submission Date:: 2012-12-07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
936975	J Robert Ready	3471 River Hills Drive Cincinnati OH 45244		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-12-05	6,000	$20.29	10,959	No	4	S	Direct
Common Stock	Acquisiton	2012-12-06	5,214	$3.72	16,173	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2012-12-06	5,214	$0.00	5,214	$3.72

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-01-20	No	4	M	Direct

Footnotes

This amended Form 4 is being filed to reflect the 12/6/12 exercise of these stock options and their conversion into common stock upon exercise, which was originally omitted from the original Form 4.
These options vested in January 2003.